Exploring the Therapeutic Landscape: The Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients With Cirrhosis

被引：0
|
作者：
Gudushauri, Nino [1 ]
Lemonjava, Irakli [1 ]
Azmaiparashvili, Zurab [1 ]
Mohan, Nandakumar [2 ]
Tskhakaia, Irakli [1 ]
Byfield, Karecia [3 ]
Anebo, Tinsae [3 ]
机构：
[1] Jefferson Einstein Hosp, Philadelphia, PA USA
[2] Einstein Healthcare Network, Philadelphia, PA USA
[3] Albert Einstein Med Ctr, Philadelphia, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036756.32599.c9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1847
引用
收藏
页码：S1330 / S1330
页数：1
相关论文
共 50 条
  • [21] Clinical prospective of SGLT2 inhibitors in atherosclerosis
    Capuano, Annalisa
    Clementi, Emilio
    Paolisso, Giuseppe
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [22] Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
    Jui-Yi Chen
    Heng-Chih Pan
    Chih-Chung Shiao
    Min-Hsiang Chuang
    Chun Yin See
    Tzu-Hsuan Yeh
    Yafei Yang
    Wen-Kai Chu
    Vin-Cent Wu
    Cardiovascular Diabetology, 22
  • [23] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [24] Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
    Chen, Jui-Yi
    Pan, Heng-Chih
    Shiao, Chih-Chung
    Chuang, Min-Hsiang
    See, Chun Yin
    Yeh, Tzu-Hsuan
    Yang, Yafei
    Chu, Wen-Kai
    Wu, Vin-Cent
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [25] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [26] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [27] The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review
    Miyamoto, Yasunori
    Honda, Akira
    Yokose, Seiji
    Nagata, Mariko
    Miyamoto, Jiro
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [28] Class effects of SGLT2 inhibitors on cardiorenal outcomes
    Kluger, Aaron Y.
    Tecson, Kristen M.
    Lee, Andy Y.
    Lerma, Edgar V.
    Rangaswami, Janani
    Lepor, Norman E.
    Cobble, Michael E.
    McCullough, Peter A.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [29] Class effects of SGLT2 inhibitors on cardiorenal outcomes
    Aaron Y. Kluger
    Kristen M. Tecson
    Andy Y. Lee
    Edgar V. Lerma
    Janani Rangaswami
    Norman E. Lepor
    Michael E. Cobble
    Peter A. McCullough
    Cardiovascular Diabetology, 18
  • [30] SGLT2 inhibitors and kidney outcomes in the real world
    Smith, Steven M.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
12345